210_PARAGRAPHS

July 2016 | Volume 7 | Article 1144.

FIGURE 1 | Effect of gut microbiota metabolome on organs and tissues..

TABLE 1 | Role of gut microbiota metabolites on health and disease..

July 2016 | Volume 7 | Article 1144.

such as plant
metabolomics, as reported by Stashenko et al.  who used
SPME-GC-MS for sampling the volatile plant metabolites, or
for example, by Akhatou et al.  who combined GC-
MS with multivariate statistical techniques to characterize the
primary metabolome of diﬀerent strawberry cultivars, and to
study the inﬂuence of multiple agronomic conditions. Moreover,
as reported by Currie et al.  GC-MS has proved useful
in microbial metabolomics related to pharmaceutical studies
to analyze the endogenous metabolite levels produced by
Pseudomonas putida in response to six pharmaceuticals; or in
food studies, when used to characterize the microbial metabolite
production in: cheese (Vannini et al., 2008; Pisano et al., 2016),
probiotic food (Patrignani et al., 2009; Tabanelli et al., 2015b),
sourdough (Guerzoni et al., 2007), wine (Vernocchi et al., 2011;
Patrignani et al., 2016), sausages (Tabanelli et al., 2015a), and
ready to eat products (Siroli et al., 2015). Moreover, GC-MS
is used in clinical applications, for example to analyze volatile
compounds (SPME-GC-MS) in urine, blood, feces, hair, breath
and saliva (Mills and Walker, 2001), or to evaluate biomarkers
in several diseases, such as asthma (Gahleitner et al., 2013;
Chang et al., 2015), schizophrenia (Liu et al., 2010), depressive
disorders (Ding et al., 2014), ulcerative colitis (Kohashi et al.,
2014), and neonatal sepsis (Fanos et al., 2014). In the last
years, GC-MS has become one of the most used techniques to
study the modulation of gut microbiota as a result of nutrition
(i.e., diet, nutraceutical food consumption), diseases, drug, and
probiotic administration. Garner et al. qualitatively and
quantitatively analyzed the fecal metabolome to identify potential
biomarkers in GI diseases; Di Cagno et al. characterized
the fecal metabolome of celiac children subjected to gluten-
free diet, compared to healthy children; Francavilla et al. 
evaluated the gut metabolome of allergic children; Vitali et al.
analyzed the eﬀects of symbiotic or prebiotic foods and probiotic
foods on the human gut metabolome proﬁle (Vitali et al., 2010,
2012); De Filippis et al. evaluated the eﬀects of the Mediterranean
diet on the gut microbiota metabolome (De Filippis et al., 2015).
Moreover, De Preter 
applied this technique to make a clinical diagnosis of IBD, and
to determine the impact of prebiotics on Chron’s disease. Del
Chierico et al. characterized the gut microbiota of non-alcoholic
fatty liver disease (NAFLD), and obese pediatric patients to
unravel disease signatures (Del Chierico et al., 2016). Finally, De
Angelis et al. analyzed the fecal metabolome of children with
autism and pervasive developmental disorders (De Angelis et al.,
2013)..

July 2016 | Volume 7 | Article 1144.

Capillary Electrophoresis Mass
Spectrometry
CE may oﬀer high-analyte resolution and detect a wider spectrum
of (polar) compounds compared to HPLC, but it is properly
applicable only to charged analytes (Ramautar et al., 2013).
However, only a few studies on this subject have been published
to date, such as Soga et al.  who separated cationic, anionic
nucleotidis, and CoA metabolites to describe the coverage of.

it is possible to combine the LC and FT-IR
techniques, as performed by Walker et al.  who identiﬁed
taurine and sulfate conjugated fatty acids in feces of diabetic mice
by coupling ICR-FT/MS and UPLC-MS.
Finally, MS-based metabolomic.

July 2016 | Volume 7 | Article 1144.

The obtained spectra are complex and contain a wide
number of signals, and frequently pure metabolites can be
added to give a more in-depth clariﬁcation. This technique is
frequently employed in clinical and pharmaceutical research and
applications, in particular in the analysis of bioﬂuids and tissues,
where 1H-NMR is used to detect the modulation of metabolites
in response to cellular stresses (Lindon et al., 2003). This has also
been reported by Bro et al.  who used plasma to determine
breast cancer biomarkers, or by Villaseñor et al.  who
described the global metabolic phenotyping of acute pancreatitis,
and by Dumas et al.  who used this technique to study
metabolic syndrome and fatty liver disease..

July 2016 | Volume 7 | Article 1144.

July 2016 | Volume 7 | Article 1144.

Biﬁdobacterium biﬁdum,
Biﬁdobacterium longum subsp.
infantis, Biﬁdobacterium breve, B.
longum subsp. longum
Biﬁdobacterium adolescentis,
commensal Lactobacilli, Bacillus
subtilis Escherichia coli and
anaerobes, Bacteroidetes,
Fusobacteria, Proteobacteria,
Actinobacteria.

Colonic bacteria, Clostridium,
Peptostreptococcus anaerobius.

July 2016 | Volume 7 | Article 1144.

synthesis (Scheppach, 1994; Wong et al., 2006). In fact, substrates
that can decrease the acetate/propionate ratio may diminish
serum lipids and consequently decrease the risk of cardiovascular
disease (Wong et al., 2006). Butyrate represents the major energy
source for colonocytes and has been studied for its role in
nourishing the colonic mucosa and preventing colon cancer by
promoting cell diﬀerentiation, cell-cycle arrest and apoptosis
of transformed colonocytes (Scheppach, 1994; Velázquez et al.,
1997; Walton et al., 2013)..

acid represents a secondary metabolite that can be converted by
clostridial cluster XIVa species into butyrate, or by clostridial
cluster IX into propionate (Louis et al., 2007), thus inducing
beneﬁts by inhibiting both the propagation of harmful bacteria,
and the production of putrefactive intestinal products. Lactic acid
also participates in the intestinal peristalsis regulation (Sugawara
et al., 2016). Furthermore, lactic acid is correlated to healthy
vaginal microbiota, in fact it decreases in bacterial vaginosis, and
it’s produced by microbial species such as Lactobacillus crispatus
and Lactobacillus jensenii (Vitali et al., 2007, 2015; Cruciani
et al., 2015; Srinivasan et al., 2015). The detection of organic
acids is most commonly obtained using LC-MS and 1H-NMR
spectroscopy platforms..

Recently, Magnúsdóttir et al.  using the PubSEED
platform, assessed the genomes of 256 human gut bacteria
involved in the biosynthesis of eight B-vitamins: biotin, folate,
cobalamin, niacin, pantothenate, riboﬂavin, pyridoxine and
thiamin. In particular, the authors demonstrated that each of the
reported vitamins was produced by 40–65% of the 256 human gut
microbes (Magnúsdóttir et al., 2015). Moreover, the absorption of
some vitamins occurs in the small intestine after conjugation of
vitamins with molecules (intrinsic factors) which are produced in
the stomach. Since some vitamins are synthetized by the colonic
microbiota, they are not adsorbed by the colon but are excreted
in feces (Wilson, 2005)..

July 2016 | Volume 7 | Article 1144.

Riboﬂavin (vitamin B2) plays an essential role in cellular
metabolism, being the precursor of
the coenzymes ﬂavin
mononucleotide (FMN) and ﬂavin adenine dinucleotide (FAD)
(Li et al., 2014). Microbial riboﬂavin biosynthesis has been
extensively described in Bacillus subtilis (Perkins and Pero, 2002)
and Escherichia coli (Bacher et al., 1996, 2000). Vitamin B2 is
contained in dairy products, bananas, popcorn, green beans and
asparagus..

July 2016 | Volume 7 | Article 1144.

Finally, certain species of Clostridium (Moss et al., 1970) and
Peptostreptococcus anaerobius (Lambert and Moss, 1980) can
convert phenylalanine to benzoic acid in a multistep process
with phenylpropionic acid (toxic metabolic product) acting
as intermediate (Macfarlane and Macfarlane, 1997; Smith and
Macfarlane, 1997). The AAs are mainly detected using LC-
MS and 1H-NMR spectroscopy techniques, and also using
FT-ICR-MS..

Moreover, Jansson et al.  using FT-ICR-MS, detected
several masses related to metabolites within the tyrosine
metabolic pathway, which diﬀerentiated CD from healthy
controls. In particular, dopaquinone (a dopa oxidation product
and intermediate in the melanin formation from tyrosine)
was signiﬁcantly elevated in CD patients compared to healthy
subjects. The authors also indicated that
tryptophan and
phenyalanine were related to the ileum CD phenotype. It was
also observed, using 1H-NMR spectroscopy, that AAs in CD
patients with active disease showed a diﬀerent proﬁle (i.e.,
alanine, isoleucine, leucine, and lysine) compared to CD patients
in remission (Marchesi et al., 2007). Furthermore, metabolites
related to bile acids pathways (i.e., glycocholate) were found in
CD patients in remission (Jansson et al., 2009)..

July 2016 | Volume 7 | Article 1144.

July 2016 | Volume 7 | Article 1144.

discriminated UC patients from controls, and also found a
correlation between the gut microbiota composition and the
metabolite composition (high levels of cadaverine and taurine).
Besides, UC patients with high levels of AAs showed low fecal
concentrations of Faecalibacterium prausnitzii and therefore a
small amount of butyric acid, since this bacteria is an SCFA
producer (De Preter et al., 2015)..

In a study on mouse models, Zhang et al.  using
LC-ESI-Q-TOF/NMR, found in urine increased excretion of
hippurate, 4-hydroxylphenylacetic acid and phenylacetylglycine,
and decreased excretion of acetate and lactate, related to body
weight gain and to an alteration of gut microbial changes
(Veselkov et al., 2009). Moreover, Paul et al. identiﬁed,
1H-NMR metabolomics, a maternal
with the support of
metabolic signature that may be related to programming
oﬀspring obesity risk in rats. In particular, pregnant rats showed
high levels of circulating ketone bodies and free FA (FFA),
especially associated with gestational diabetes (Catalano, 2010).
The branched chains AA (BCAA) have also found to be related to
increased insulin resistance (Scholtens et al., 2014). In humans,
FFA are transferred through the placenta from mother to child
and are used for lipogenesis. FFA, together with the circulating
ketons, may play an important role in the early deposition
of excess of body fats in oﬀspring. The production of these
molecules in serum metabolome is normalized when it
is
associated to diet enriched with oligrofructosaccharides (FOS)
and to gut microbiota modulation (Paul et al., 2016). Respondek
et al. studied the eﬀects of FOS on the composition of
the fecal microbiota and the metabolic parameters in animal
models of diet-induced obesity (Respondek et al., 2013). The
authors ﬁrstly found that the strains particularly stimulated.

Cystic Fibrosis (CF)
Regarding CF disease, the majority of studies on the microbiota
metabolome concern lung and the upper airways. It was observed
that in CF the production of isoprene is associated to either
Gram+ and Gram- species (Kuzma et al., 1995), while the
production of hydrogen cyanide is prevalently associated to
Pseudomonas aeruginosa, (Carterson et al., 2004; Cody et al.,
2009). Robroeks et al. analyzed exhaled breath samples
by GC-TOF-MS, and they managed to discriminate between
CF and healthy controls, mainly based on the presence of C5–
C16 hydrocarbons and N-methyl-2-methylpropylamine. Barker
et al. reported a signiﬁcantly lower level of dimethyl
sulﬁde (probably associated to microbial metabolism), detected
by GC-MS in CF patients compared to controls. On the other
side, Montuschi et al.  using 1H-NMR forexhaled breath
condensate (EBC) analysis, detected signiﬁcantly higher values
of ethanol, acetate, 2-propanol and acetone in CF patients, which
diﬀerentiated them from controls, whereas acetate, ethanol, 2-
propanol and methanol were found to be relevant metabolites
for distinguishing between patients with stable CF and patients
with unstable CF. Moreover, 2-Propanol, which represents an
enzyme-mediated product of acetone reduction, was detected in
a breath sample of CF colonized by P. aeruginosa (Wang et al.,
2006). The high level of ethanol in EBC samples of CF, detected
by MS based metabolomics, could also be related to the decreased
capacity of P. aeruginosa to oxidize ethanol to acetate (Wang
et al., 2006). On the contrary, elevated acetate concentrations in
healthy subjects may reﬂect resident bacteria in the oral cavity,
such as Streptococcus mutans, debasing pyruvate into metabolic
end products, such as acetate and lactate (Korithoski et al., 2008)..

Non-alcoholic Fatty Liver Disease (NAFLD)
Several VOCs, including ethanol, seem to be produced by colonic
bacteria and may have toxic eﬀects on the host after intestinal
absorption and delivery to the liver via the portal vein (Raman
et al., 2013). Moreover, Raman et al.  using SPME-GC-MS,
identiﬁed esters (i.e., ethyl propanoate, butyl butanoate, methyl
pentanoate, methyl acetate) in fecal samples of obese NAFLD
patients more frequently than in healthy controls..

The bacterial production of SCFAs and ethanol by several
gut microbes is well known, but very little is known about
bacteria and biochemical pathways that may be involved in
ester production in the intestinal microbiota, even though most
of the esters linked to NAFLD are derivatives of short chain
aliphatic alcohols and carboxylic acids (Raman et al., 2013).
Also Del Chierico et al. evaluated the gut microbiota
proﬁling of NAFLD and obese patients. The authors evidenced,
with the support of multivariate analysis, that OTUs such as
Oscillospira, Ricknellaceae, Parabacteroides, Bacteroides fragilis,
Sutterella, and Lachnospiraceae, and metabolites such as 4-
Methyl-2-pentanone, 1-butanol and 2-butanone (detected with.

July 2016 | Volume 7 | Article 1144.

fragilis improves intestinal health,.

July 2016 | Volume 7 | Article 1144.

Ahmed, I., Greenwood, R., Costello Bde, L., Ratcliﬀe, N. M., and Probert,
C. S.  An investigation of
fecal volatile organic metabolites in
irritable bowel syndrome. PLoS ONE 8:e58204. doi: 10.1371/journal.pone.00
58204.

Alm, L.  Eﬀect of fermentation on B-vitamin content of milk in Sweden. J..

Arora, T., and Sharma, R.  Fermentation potential of the gut microbiome:
implications for energy homeostasis and weight management. Nutr. Rev. 69,
99–106. doi: 10.1111/j.1753-4887.2010.00365.x.

Bacher, A., Eberhardt, S., and Richter, G.  “Biosynthesis of riboﬂavin,” in
Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology,
ed F. C. Neidhardt (Washington, DC: ASM Press), 657–664..

Bakhtiar, R., Ramos, L., and Tse, F. L. S.  Toxicokinetic assessment of
methylphenidate (Ritalin) in a 13-week oral toxicity study in dogs. Biomed.
Chromatogr. 18, 45–50. doi: 10.1002/bmc.290.

Bathena, S. P., Thakare, R., Gautam, N., Mukherjee, S., Olivera, M., Meza, J.,
et al.  Urinary bile acids as biomarkers for liver diseases I. Stability
of the baseline proﬁle in healthy subjects. Toxicol. Sci. 143, 296–307. doi:
10.1093/toxsci/kfu227.

 Bile salt hydrolase
activity in probiotics. Appl. Environ. Microbiol. 72, 1729–1738. doi:
10.1128/AEM.72.3.1729-1738.2006.

Belkaid, Y., and Hand, T. W.  Role of the microbiota in immunity and.

Best, C. A., and Laposata, M.  Fatty acid ethyl esters: toxic non-oxidative
intake. Front. Biosci. 8,.

Binder, H. J.  Role of colonic short-chain fatty acid transport in diarrhea.
Annu. Rev. Physiol. 72, 297–313. doi: 10.1146/annurev-physiol-021909-135817
Bjerrum, J. T., Wang, Y., Hao, F., Coskun, M., Ludwig, C., Günther, U., et al.
 Metabonomics of human fecal extracts characterize ulcerative colitis,
Crohn’s disease and healthy individuals. Metabolomics 11, 122–133. doi:
10.1007/s11306-014-0677-3.

Bone, E., Tamm, A., and Hill, M.  The production of urinary phenols by gut
bacteria and their possible role in the causation of large bowel cancer. Am. J.
Clin. Nutr. 29, 1448–1454..

Bortolini, O., Medici, A., and Poli, S.  Biotransformations on steroid nucleus.

Bro, R., Kamstrup-Nielsen, M. H., Engelsen, S. B., Savorani, F., Rasmussen, M. A.,
Hansen, L., et al.  Forecasting individual breast cancer risk using plasma
metabolomics and biocontours. Metabolomics 11, 1376–1380. doi: 10.1007/
s11306-015-0793-8.

Bunge, M., Araghipour, N., Mikoviny, T., Dunkl, J., Schnitzhofer, R., Hansel, A.,
et al.  On-line monitoring of microbial volatile metabolites by proton
transfer reaction-mass spectrometry. Appl. Environ. Microbiol. 74, 2179–2186.
doi: 10.1128/AEM.02069-07.

Calabrò, A., Gralka, E., Luchinat, C., Saccenti, E., and Tenori, L.  A
metabolomic perspective on coeliac disease. Autoimmune Dis. 2014:756138.
doi: 10.1155/2014/756138.

Calvani, R., Miccheli, A., Capuani, G., Tomassini Miccheli, A., Puccetti, C., Delﬁni,
M., et al.  Gut microbiome-derived metabolites characterize a peculiar
obese urinary metabotype. Int. J. Obes. 34, 1095–1098. doi: 10.1038/ijo.2010.44
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N.
M., et al.  Changes in gut microbiota control metabolic endotoxemia-
induced inﬂammation in high-fat diet-induced obesity and diabetes in mice.
Diabetes 57, 1470–1481. doi: 10.2337/db07-1403.

Cani, P. D., and Delzenne, N. M.  The role of the gut microbiota in
energy metabolism and metabolic disease. Curr. Pharm. Des. 15, 1546–1558.
doi: 10.2174/138161209788168164.

Carroll, I. M., Ringel-Kulka, T., Siddle, J. P., and Ringel, Y.  Alterations
in composition and diversity of the intestinal microbiota in patients with
diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24,
521–530, e248. doi: 10.1111/j.1365-2982.2012.01891.x.

Carterson, A. J., Morici, L. A., Jackson, D. W., Frisk, A., Lizewski, S. E.,
Jupiter, R., et al.  The transcriptional regulator AlgR controls cyanide.

July 2016 | Volume 7 | Article 1144.

Caspi, R., Foerster, H., Fulcher, C. A., Kaipa, P., Krummenacker, M., Latendresse,
M., et al.  The MetaCyc database of metabolic pathways and enzymes
and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 36,
D623–D631. doi: 10.1093/nar/gkm900.

Catalano, P. M.  Obesity, insulin resistance, and pregnancy outcome..

Chambers, E. S., Viardot, A., Psichas, A., Morrison, D. J., Murphy, K. G., Zac-
Varghese, S. E., et al.  Eﬀects of targeted delivery of propionate to the
human colon on appetite regulation, body weight maintenance and adiposity
in overweight adults. Gut 64, 1744–1754. doi: 10.1136/gutjnl-2014-307913
Chang, C., Guo, Z., He, B., and Yao, W.  Metabolic alterations in the sera of
Chinese patients with mild persistent asthma: a GC-MS-based metabolomics
analysis. Acta Pharmacol. Sin. 36, 1356–1366. doi: 10.1038/aps.2015.102.

Chow, J., Panasevich, M. R., Alexander, D., Vester Boler, B. M., Rossoni Serao, M.
C., Faber, T. A., et al.  Fecal metabolomics of healthy breast-fed versus
formula-fed infants before and during in vitro batch culture fermentation. J.
Proteome Res. 13, 2534–2542. doi: 10.1021/pr500011w.

Clayton, T. A.  Metabolic diﬀerences underlying two distinct rat urinary
phenotypes, a suggested role for gut microbial metabolism of phenylalanine
and a possible connection to autism. FEBS Lett. 586, 956–961. doi:
10.1016/j.febslet.2012.01.049.

Cliﬀord, M. N.  Diet-derived phenols in plasma and tissues and their
implications for health. Planta Med. 70, 1103–1114. doi: 10.1055/s-2004-
835835.

Cody, W. L., Pritchett, C. L., Jones, A. K., Carterson, A. J., Jackson, D., Frisk,
A., et al.  Pseudomonas aeruginosa AlgR controls cyanide production
in an AlgZ-dependent manner. J. Bacteriol. 191, 2993–3002. doi: 10.1128/
JB.01156-08.

Collino, S., Martin, F. P. J., and Rezzi, S.  Clinical Metabolomics paves the
way towards future healthcare strategies. Br. J. Clin. Pharmacol. 75, 619–629.
doi: 10.1111/j.1365-2125.2012.04216.x.

Couteau, D., McCartney, A. L., Gibson, G. R., Williamson, G., and Faulds, C.
B.  Isolation and characterization of human colonic bacteria able to
hydrolyse chlorogenic acid. J. Appl. Microbiol. 90, 873–881. doi: 10.1046/j.1365-
2672.2001.01316.x.

Cruciani, F., Biagi, E., Severgnini, M., Consolandi, C., Calanni, F., Donders,
G., et al.  Development of a microarray-based tool to characterize
vaginal bacterial ﬂuctuations and application to a novel antibiotic treatment
for bacterial vaginosis. Antimicrob. Agents Chemother. 59, 2825–2834. doi:
10.1128/AAC.00225-15.

Davidson, R. T., Foley, A. L., Engelke, J. A., and Suttie, J. W.  Conversion of
dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut
bacteria. J. Nutr. 128, 220–223..

Dawson, P. A., Lan, T., and Rao, A.  Bile acid transporters. J. Lipid Res. 50,.

De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A.,
Serrazzanetti, D. I., et al.  Fecal microbiota and metabolome of children
with autism and pervasive developmental disorder not otherwise speciﬁed.
PLoS ONE 8:e76993. doi: 10.1371/journal.pone.0076993.

De Boever, P., Wouters, R., Verschaeve, L., Berckmans, P., Schoeters, G., and
Verstraete, W.  Protective eﬀect of the bile salt hydrolase-active
Lactobacillus reuteri against bile salt cytotoxicity. Appl. Microbiol. Biotechnol.
53, 709–714. doi: 10.1007/s002530000330.

De Filippis, F., Pellegrini, N., Vannini, L., Jeﬀery, I. B., La Storia, A., Laghi, L.,
et al.  High-level adherence to a Mediterranean diet beneﬁcially impacts
the gut microbiota and associated metabolome. Gut. doi: 10.1136/gutjnl-2015-
309957. [Epub ahead of print]..

Deguchi, Y., Morishita, T., and Mutai, M.  comparative studies on synthesis
of water-soluble vitamins among human species of biﬁdobacteria. Agric. Biol.
Chem. 49, 13–19..

Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani,
D., et al.  Gut microbiota proﬁling of pediatric NAFLD and obese
patients unveiled by an integrated meta-omics based approach. Hepatology. doi:
10.1002/hep.28572. [Epub ahead of print]..

Del Chierico, F., Vernocchi, P., Bonizzi, L., Carsetti, R., Castellazzi, A. M.,
Dallapiccola, B., et al.  Early-life gut microbiota under physiological
and pathological conditions:
the central role of combined meta-omics-
based approaches. J. Proteomics 75, 4580–4587. doi: 10.1016/j.jprot.2012.
02.018.

De Preter, V.  Metabolomics in the clinical diagnosis of inﬂammatory bowel.

De Preter, V., Machiels, K., Joossens, M., Arijs, I., Matthys, C., Vermeire, S.,
et al.  Faecal metabolite proﬁling identiﬁes medium-chain fatty acids as
discriminating compounds in IBD. Gut 64, 447–458. doi: 10.1136/gutjnl-2013-
306423.

De Preter, V., and Verbeke, K.  Metabolomics as a diagnostic tool in
gastroenterology. World J. Gastrointest. Pharmacol. Ther. 4, 97–107. doi:
10.4292/wjgpt.v4.i4.97.

Dettmer, K., Aronov, P. A., and Hammock, B. D.  Mass spectrometry-based.

De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun,
C., Duchampt, A., et al.  Microbiota-generated metabolites promote
metabolic beneﬁts via gut-brain neural circuits. Cell 156, 84–96. doi:
10.1016/j.cell.2013.12.016.

De Weirdt, R., Possemiers, S., Vermeulen, G., Moerdijk-Poortvliet, T. C. W.,
Boschker, H. T. S., Verstraete, W., et al.  Human faecal microbiota
display variable patterns of glycerol metabolism. FEMS Microbiol. Ecol. 74,
601–611. doi: 10.1111/j.1574-6941.2010.00974.x.

Di Cagno, R., De Angelis, M., De Pasquale, I., Ndagijimana, M., Vernocchi, P.,
Ricciuti, P., et al.  Duodenal and faecal microbiota of celiac children:
molecular, phenotype and metabolome characterization. BMC Microbiol.
11:219. doi: 10.1186/1471-2180-11-219.

Dicksved, J., Halfvarson, J., Rosenquist, M., Järnerot, G., Tysk, C., Apajalahti, J.,
et al.  Molecular analysis of the gut microbiota of identical twins with
Crohn’s disease. ISME J. 2, 716–727. doi: 10.1038/ismej.2008.37.

Ding, X., Yang, S., Li, W., Liu, Y., Li, Z., Zhang, Y., et al.  The potential
biomarker panels for identiﬁcation of major depressive disorder (MDD)
patients with and without early life stress (ELS) by metabonomic analysis. PLoS
ONE 9:e97479. doi: 10.1371/journal.pone.0097479.

Dole, M. N., Patel, P. A., Sawant, S. D., and Shedpure, P. S.  Advance
applications of fourier transform infrared spectroscopy. Int. J. Pharm. Sci. Rev.
Res. 7, 159–166..

Donohoe, D. R., Garge, N., Zhang, X., Sun, W., O’Connell, T. M., Bunger, M.
K., et al.  The Microbiome and Butyrate Regulate Energy Metabolism
and Autophagy in the Mammalian Colon. Cell Metab. 13, 517–526. doi:
10.1016/j.cmet.2011.02.018.

Dumas, M. E., Kinross, J., and Nicholson, J. K.  Metabolic phenotyping
and systems biology approaches to understanding metabolic syndrome and
fatty liver disease. Gastroenterology 146, 46–62. doi: 10.1053/j.gastro.2013.
11.001.

 Metabolomics: current analytical
platforms and methodologies. TrAC Trends Anal. Chem. 24, 285–294. doi:
10.1016/j.trac.2004.11.021.

July 2016 | Volume 7 | Article 1144.

Fiehn, O., Kopka, J., Dörmann, P., Altmann, T., Trethewey, R. N., and Willmitzer,
L.  Metabolite proﬁling for plant functional genomics. Nat. Biotechnol.
18, 1157–1161. doi: 10.1038/81137.

Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P., and Forano, E.  Microbial
degradation of complex carbohydrates in the gut. Gut Microbes 3, 289–306. doi:
10.4161/gmic.19897.

Francavilla, R., Calasso, M., Calace, L., Siragusa, S., Ndagijimana, M., Vernocchi,
P., et al.  Eﬀect of lactose on gut microbiota and metabolome of
infants with cow’s milk allergy. Pediatr. Allergy Immunol. 23, 420–427. doi:
10.1111/j.1399-3038.2012.01286.x.

Francavilla, R., Ercolini, D., Piccolo, M., Vannini, L., Siragusa, S., De Filippis, F.,
et al.  Salivary microbiota and metabolome associated with celiac disease.
Appl. Environ. Microbiol. 80, 3416–3425. doi: 10.1128/AEM.00362-14.

Gahleitner, F., Guallar-Hoyas, C., Beardsmore, C. S., Pandya, H. C., and Thomas,
C. P.  Metabolomics pilot study to identify volatile organic compound
markers of childhood asthma in exhaled breath. Bioanalysis 5, 2239–2247. doi:
10.4155/bio.13.184.

Garner, C. E., Smith, S., de Lacy Costello, B., White, P., Spencer, R., Probert, C. S.
J., et al.  Volatile organic compounds from feces and their potential for
diagnosis of gastrointestinal disease. FASEB J. 21, 1675–1688. doi: 10.1096/fj.06-
6927com.

Groh, H., Schade, K., and Hörhold-Schubert, C.  Steroid metabolism
J. Basic Microbiol. 33, 59–72. doi:.

Guerzoni, M. E., Vernocchi, P., Ndagijimana, M., Gianotti, A., and Lanciotti,
R.  Generation of aroma compounds in sourdough: eﬀects of stress
exposure and lactobacilli–yeasts interactions. Food Microbiol. 24, 139–148. doi:
10.1016/j.fm.2006.07.007.

Kamada, N., Chen, G. Y., Inohara, N., and Núñez, G.  Control of pathogens
and pathobionts by the gut microbiota. Nat. Immunol. 14, 685–690. doi:
10.1038/ni.2608.

Kidd, P.  Autism, an extreme challenge to integrative medicine. Part: 1: The.

Kim, S. J., Kim, S. H., Kim, J. H., Hwang, S., and Yoo, H. J.  Understanding
metabolomics in biomedical research. Endocrinol. Metab. Seoul Korea 31, 7–16.
doi: 10.3803/EnM.2016.31.1.7.

Kinross, J. M., Darzi, A. W., and Nicholson, J. K.  Gut microbiome-host
interactions in health and disease. Genome Med. 3, 14. doi: 10.1186/gm228
Kleerebezem, M., and Vaughan, E. E.  Probiotic and gut lactobacilli
and biﬁdobacteria: molecular approaches to study diversity and activity.
Annu. Rev. Microbiol. 63, 269–290. doi: 10.1146/annurev.micro.091208.
073341.

Kohashi, M., Nishiumi, S., Ooi, M., Yoshie, T., Matsubara, A., Suzuki, M.,
et al.  A novel gas chromatography mass spectrometry-based serum
diagnostic and assessment approach to ulcerative colitis. J. Crohns Colitis 8,
1010–1021. doi: 10.1016/j.crohns.2014.01.024.

Konishi, Y., and Kobayashi, S.  Transepithelial transport of chlorogenic
acid, caﬀeic acid, and their colonic metabolites in intestinal caco-2 cell
monolayers. J. Agric. Food Chem. 52, 2518–2526. doi: 10.1021/jf035407c.

Korithoski, B., Lévesque, C. M., and Cvitkovitch, D. G.  The involvement
of the pyruvate dehydrogenase E1alpha subunit, in Streptococcus mutans
acid tolerance. FEMS Microbiol. Lett. 289, 13–19. doi: 10.1111/j.1574-
6968.2008.01351.x.

Krajmalnik-Brown, R., Ilhan, Z.-E., Kang, D.-W., and DiBaise, J. K.  Eﬀects
of gut microbes on nutrient absorption and energy regulation. Nutr. Clin. Pract.
27, 201–214. doi: 10.1177/0884533611436116.

Kumar, S., Misra, A., and Ghoshal, U. C.  Patients with irritable bowel
syndrome exhale more hydrogen than healthy subjects in fasting state. J.
Neurogastroenterol. Motil. 16, 299–305. doi: 10.5056/jnm.2010.16.3.299.

Kusano, M., Mendez, E., and Furton, K. G.  Comparison of the volatile
organic compounds from diﬀerent biological specimens for proﬁling potential.
J. Forensic Sci. 58, 29–39. doi: 10.1111/j.1556-4029.2012.02215.x.

Harrigan, G. G., and Goodacre, R.  Metabolic Proﬁling: Its Role in Biomarker
Discovery and Gene Function Analysis. Boston, MA: Springer US; Imprint;
Springer..

Kuzma, J., Nemecek-Marshall, M., Pollock, W. H., and Fall, R.  Bacteria
produce the volatile hydrocarbon isoprene. Curr. Microbiol. 30, 97–103. doi:
10.1007/BF00294190.

Lambert, M. A., and Moss, C. W.  Production of p-hydroxyhydrocinnamic
acid from tyrosine by Peptostreptococcus anaerobius. J. Clin. Microbiol. 12,
291–293..

Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T.,
et al.  Microbiota modulate behavioral and physiological abnormalities
associated with neurodevelopmental disorders. Cell 155, 1451–1463. doi:
10.1016/j.cell.2013.11.024.

Islam, K. B., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., et al.  Bile
acid is a host factor that regulates the composition of the cecal microbiota in
rats. Gastroenterology 141, 1773–1781. doi: 10.1053/j.gastro.2011.07.046.

Jacobs, D. M., Deltimple, N., van Velzen, E., van Dorsten, F. A., Bingham, M.,
Vaughan, E. E., et al.  NMR metabolite proﬁling of feces as a tool
to assess the impact of nutrition on the human microbiome. NMR Biomed. 21,
615–626. doi: 10.1002/nbm.1233.

Jaganath, I. B., Mullen, W., Lean, M. E. J., Edwards, C. A., and Crozier,
A.  In vitro catabolism of rutin by human fecal bacteria and the.

Lamichhane, S., Yde, C. C., Schmedes, M. S., Jensen, H. M., Meier, S., and Bertram,
H. C.  Strategy for nuclear-magnetic-resonance-based metabolomics
of human feces. Anal. Chem. 87, 5930–5937. doi: 10.1021/acs.analchem.
5b00977.

July 2016 | Volume 7 | Article 1144.

Lechner, M., and Rieder, J.  Mass spectrometric proﬁling of low-molecular-
weight volatile compounds–diagnostic potential and latest applications. Curr.
Med. Chem. 14, 987–995. doi: 10.2174/092986707780362916.

Martens, J. H., Barg, H., Warren, M. J., and Jahn, D.  Microbial production
of vitamin B12. Appl. Microbiol. Biotechnol. 58, 275–285. doi: 10.1007/s00253-
001-0902-7.

Li, L., Hu, L., Han, L.-P., Ji, H., Zhu, Y., Wang, X., et al.  Expression of turtle
riboﬂavin-binding protein represses mitochondrial electron transport gene
expression and promotes ﬂowering in Arabidopsis. BMC Plant Biol. 14:381. doi:
10.1186/s12870-014-0381-5.

Lin, H. V., Frassetto, A., Kowalik, E. J. Jr., Nawrocki, A. R., Lu, M. M., Kosinski,
J. R., et al.  Butyrate and propionate protect against diet-induced
obesity and regulate gut hormones via free fatty acid receptor 3-independent
mechanisms. PLoS ONE 7:e35240. doi: 10.1371/journal.pone.0035240.

Lindon, J. C., Holmes, E., and Nicholson, J. K.  So what’s the deal with.

Liu, J.-Y., Li, N., Yang, J., Li, N., Qiu, H., Ai, D., et al.  Metabolic proﬁling
of murine plasma reveals an unexpected biomarker in rofecoxib-mediated
cardiovascular events. Proc. Natl. Acad. Sci. U.S.A. 107, 17017–17022. doi:
10.1073/pnas.1011278107.

Lord, R. S., and Bralley, J. A.  Clinical applications of urinary organic acids..

Martin, F.-P. J., Collino, S., Rezzi, S., and Kochhar, S.  Metabolomic
applications to decipher gut microbial metabolic inﬂuence in health and
disease. Front. Physiol. 3:113. doi: 10.3389/fphys.2012.00113.

Mayo, B., and van Sinderen, D. (eds.).  Biﬁdobacteria: Genomics and.

Michielan, A., and D’Incà, R.  Intestinal permeability in inﬂammatory
bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Med.
Inﬂamm. 2015:628157. doi: 10.1155/2015/628157.

Mills, G. A., and Walker, V.  Headspace solid-phase microextraction
application to metabolic
J. Chromatogr. B. Biomed. Sci. App. 753, 259–268. doi:.

Moco, S., Collino, S., Rezzi, S., and Martin, F.-P. J.  Metabolomics
research. Pediatr. Res. 73, 570–576. doi:.

Moss, C. W., Lambert, M. A., and Goldsmith, D. J.  Production of.

Mueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank,
A., et al.  Plasma levels of trimethylamine-N-oxide are confounded
by impaired kidney function and poor metabolic control. Atherosclerosis 243,
638–644. doi: 10.1016/j.atherosclerosis.2015.10.091.

Louis, P., Hold, G. L., and Flint, H. J.  The gut microbiota, bacterial
metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672. doi:
10.1038/nrmicro3344.

Mukhopadhya, I., Hansen, R., El-Omar, E. M., and Hold, G. L.  IBD-what
role do Proteobacteria play? Nat. Rev. Gastroenterol. Hepatol. 9, 219–230. doi:
10.1038/nrgastro.2012.14.

Louis, P., Scott, K. P., Duncan, S. H., and Flint, H. J.  Understanding the
eﬀects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol.
102, 1197–1208. doi: 10.1111/j.1365-2672.2007.03322.x.

Macfarlane, G. T., and Gibson, G. R.  “Microbiological aspects of SCFA
production in the large bowel,” in Physiological and Clinical Aspects of Short-
Chain Fatty Acids, eds J. H. Cummings, J. L. Rombeau, and T. Sakata
(Cambridge; New York, NY: Cambridge University Press), 87–105..

Macfarlane, G. T., and Macfarlane, S.  Human colonic microbiota:
ecology, physiology and metabolic potential of intestinal bacteria. Scand. J.
Gastroenterol. Suppl. 222, 3–9. doi: 10.1080/00365521.1997.11720708.

Macfarlane, S., and Macfarlane, G. T.  “Proteolysis and amino acid
fermentation.,” in Human Colonic Bacteria: Role in Nutrition, Physiology, and
Pathology, eds G. R. Gibson and G. T. Macfarlane (Boca Raton, FL: CRC press),
75–100..

Marín, L., Miguélez, E. M., Villar, C. J., and Lombó, F.  Bioavailability of
dietary polyphenols and gut microbiota metabolism: antimicrobial properties.
Biomed Res. Int. 2015:905215. doi: 10.1155/2015/905215.

Nassar, A.-E. F., and Talaat, R. E.  Strategies for dealing with metabolite
elucidation in drug discovery and development. Drug Discov. Today 9, 317–327.
doi: 10.1016/S1359-64463018-6.

Naz, S., Vallejo, M., García, A., and Barbas, C.  Method validation strategies
involved in non-targeted metabolomics. J. Chromatogr. A 1353, 99–105. doi:
10.1016/j.chroma.2014.04.071.

Ndagijimana, M., Laghi, L., Vitali, B., Placucci, G., Brigidi, P., and Guerzoni, M.
E.  Eﬀect of a synbiotic food consumption on human gut metabolic
proﬁles evaluated by  Nuclear Magnetic Resonance spectroscopy. Int. J.
Food Microbiol. 134, 147–153. doi: 10.1016/j.ijfoodmicro.2009.04.016.

 Opinion: gut
microorganisms, mammalian metabolism and personalized health care. Nat.
Rev. Microbiol. 3, 431–438. doi: 10.1038/nrmicro1152.

Nicholson, J. K., and Lindon, J. C.  Systems biology: metabonomics. Nature.

Noda, H., Akasaka, N., and Ohsugi, M.  Biotin production by biﬁdobacteria..

July 2016 | Volume 7 | Article 1144.

Oresic, M., Simell, S., Sysi-Aho, M., Näntö-Salonen, K., Seppänen-Laakso, T.,
Parikka, V., et al.  Dysregulation of lipid and amino acid metabolism
precedes islet autoimmunity in children who later progress to type 1 diabetes.
J. Exp. Med. 205, 2975–2984. doi: 10.1084/jem.20081800.

Parkar, S. G., Trower, T. M., and Stevenson, D. E.  Fecal microbial
metabolism of polyphenols and its eﬀects on human gut microbiota. Anaerobe
23, 12–19. doi: 10.1016/j.anaerobe.2013.07.009.

Patrignani, F., Burns, P., Serrazanetti, D., Vinderola, G., Reinheimer, J., Lanciotti,
R., et al.  Suitability of high pressure-homogenized milk for the
production of probiotic fermented milk containing Lactobacillus paracasei and
Lactobacillus acidophilus. J. Dairy Res. 76, 74. doi: 10.1017/S0022029908003828
Patrignani, F., Chinnici, F., Serrazanetti, D. I., Vernocchi, P., Ndagijimana, M.,
Riponi, C., et al.  Production of volatile and sulfur compounds by
10 saccharomyces cerevisiae strains inoculated in trebbiano must. Front.
Microbiol. 7:243. doi: 10.3389/fmicb.2016.00243.

Paul, H. A., Bomhof, M. R., Vogel, H. J., and Reimer, R. A.  Diet-
induced changes in maternal gut microbiota and metabolomic proﬁles
inﬂuence programming of oﬀspring obesity risk in rats. Sci. Rep. 6:20683. doi:
10.1038/srep20683.

Pawliszyn, J.  Solid Phase Microextraction: Theory and Practice. New York,.

Pence, H. E., and Williams, A.  ChemSpider: an online chemical
information resource. J. Chem. Educ. 87, 1123–1124. doi: 10.1021/ed100697w
Penders, J., Thijs, C., van den Brandt, P. A., Kummeling, I., Snijders, B., Stelma,
F., et al.  Gut microbiota composition and development of atopic
manifestations in infancy: the KOALA Birth Cohort Study. Gut 56, 661–667.
doi: 10.1136/gut.2006.100164.

Perkins, N. J., and Pero, J.  “Vitamin biosynthesis,” in Bacillus subtilis and
Its Closest Relatives from Genes to Cells, eds A. L. Sonenshein, R. Losick, and J.
A. Hoch (Washington, DC: ASM Press), 271–286..

Phipps, A. N., Stewart, J., Wright, B., and Wilson, I. D.  Eﬀect of diet on
the urinary excretion of hippuric acid and other dietary-derived aromatics
in rat. A complex interaction between diet, gut microﬂora and substrate
speciﬁcity. Xenobiotica Fate Foreign Compd. Biol. Syst. 28, 527–537. doi:
10.1080/004982598239443.

Putignani, L., Del Chierico, F., Vernocchi, P., Cicala, M., Cucchiara, S.,
Dallapiccola, B., et al.  Gut microbiota dysbiosis as risk and premorbid
factors of IBD and IBS along the childhood-adulthood transition. Inﬂamm.
Bowel Dis. 22, 487–504. doi: 10.1097/MIB.0000000000000602.

Qiu, Y., Cai, G., Su, M., Chen, T., Liu, Y., Xu, Y., et al.  Urinary
metabonomic study on colorectal cancer. J. Proteome Res. 9, 1627–1634. doi:
10.1021/pr901081y.

Raamsdonk, L. M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M.
C., et al.  A functional genomics strategy that uses metabolome data
to reveal the phenotype of silent mutations. Nat. Biotechnol. 19, 45–50. doi:
10.1038/83496.

Raimondi, S., Anighoro, A., Quartieri, A., Amaretti, A., Tomás-Barberán, F. A.,
Rastelli, G., et al.  Role of biﬁdobacteria in the hydrolysis of chlorogenic
acid. Microbiologyopen 4, 41–52. doi: 10.1002/mbo3.219.

Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliﬀe, N. M., Smith, S.,
et al.  Fecal microbiome and volatile organic compound metabolome
in obese humans with nonalcoholic fatty liver disease. Clin. Gastroenterol.
Hepatol. 11, 868–875.e1–3. doi: 10.1016/j.cgh.2013.02.015.

Ramautar, R., Somsen, G. W., and de Jong, G. J.  CE-MS for metabolomics:
developments and applications in the period 2010-2012. Electrophoresis 34,
86–98. doi: 10.1002/elps.201200390.

Robroeks, C. M. H. H. T., van Berkel, J. J. B. N., Dallinga, J. W., Jöbsis, Q.,
Zimmermann, L. J. I., Hendriks, H. J. E., et al.  Metabolomics of volatile
organic compounds in cystic ﬁbrosis patients and controls. Pediatr. Res. 68,
75–80. doi: 10.1203/PDR.0b013e3181df4ea0.

Roediger, W. E., Duncan, A., Kapaniris, O., and Millard, S.  Reducing
sulfur compounds of the colon impair colonocyte nutrition: implications
for ulcerative colitis. Gastroenterology 104, 802–809. doi: 10.1016/0016-
50851016-B.

Rosselló-Mora, R., Lucio, M., Peña, A., Brito-Echeverría, J., López-López, A.,
Valens-Vadell, M., et al.  Metabolic evidence for biogeographic isolation
of the extremophilic bacterium Salinibacter ruber. ISME J. 2, 242–253. doi:
10.1038/ismej.2007.93.

Rossi, M., and Amaretti, A.  “Probiotic properties of Biﬁdobacteria,” in
Biﬁdobacteria: Genomics and Molecular Aspects, eds M. Baltasar and D. van
Sinderen (Norfolk: Caister Academic), 97–123..

Russell, D. W., and Setchell, K. D.  Bile acid biosynthesis. Biochemistry.

Sabatino, A. D., Morera, R., Ciccocioppo, R., Cazzola, P., Gotti, S., Tinozzi,
F. P., et al.  Oral butyrate for mildly to moderately active Crohn’s
disease. Aliment. Pharmacol. Ther. 22, 789–794. doi: 10.1111/j.1365-2036.2005.
02639.x.

Savorani, F., Rasmussen, M. A., Mikkelsen, M. S., and Engelsen, S. B.  A
primer to nutritional metabolomics by NMR spectroscopy and chemometrics.
Food Res. Int. 54, 1131–1145. doi: 10.1016/j.foodres.2012.12.025.

Scalan, P. D., Buckling, A., Kong, W., Wild, Y., Lynch, S. W., and Harrison,
F.  Gut dysbiosis in cystic ﬁbrosis. J. Cyst. Fibros. 11, 454–455. doi:
10.1016/j.jcf.2012.03.007.

Scheppach, W.  Eﬀects of short chain fatty acids on gut morphology and.

Scheppach, W., Pomare, E. W., Elia, M., and Cummings, J. H.  The
contribution of the large intestine to blood acetate in man. Clin. Sci. 80,
177–182. doi: 10.1042/cs0800177.

Scheppach, W., Sommer, H., Kirchner, T., Paganelli, G. M., Bartram, P., Christl, S.,
et al.  Eﬀect of butyrate enemas on the colonic mucosa in distal ulcerative
colitis. Gastroenterology 103, 51–56. doi: 10.1016/0016-50851094-K.

Schöller, C., Molin, S., and Wilkins, K.  Volatile metabolites from some
gram-negative bacteria. Chemosphere 35, 1487–1495. doi: 10.1016/S0045-
65350209-9.

Scholtens, D. M., Muehlbauer, M. J., Daya, N. R., Stevens, R. D., Dyer, A. R., Lowe,
L. P., et al.  Metabolomics reveals broad-scale metabolic perturbations
in hyperglycemic mothers during pregnancy. Diabetes Care 37, 158–166. doi:
10.2337/dc13-0989.

Selma, M. V., Espín, J. C., and Tomás-Barberán, F. A.  Interaction between
phenolics and gut microbiota: role in human health. J. Agric. Food Chem. 57,
6485–6501. doi: 10.1021/jf902107d.

Shahani, K. M., and Chandan, R. C.  Nutritional and healthful aspects of
cultured and culture-containing dairy foods. J. Dairy Sci. 62, 1685–1694. doi:
10.3168/jds.S0022-03023481-5.

Silla Santos, M. H.  Biogenic amines: their importance in foods. Int. J. Food.

Siroli, L., Patrignani, F., Serrazanetti, D. I., Tabanelli, G., Montanari, C., Gardini,
F., et al.  Lactic acid bacteria and natural antimicrobials to improve the.

July 2016 | Volume 7 | Article 1144.

Sivsammye, G., and Sims, H. V.  Presumptive identiﬁcation of Clostridium
diﬃcile by detection of p-cresol in prepared peptone yeast glucose broth
supplemented with p-hydroxyphenylacetic acid.
J. Clin. Microbiol. 28,
1851–1853..

Smirnov, K. S., Maier, T. V., Walker, A., Heinzmann, S. S., Forcisi, S., Martinez, I.,
et al.  Challenges of metabolomics in human gut microbiota research.
Int. J. Med. Microbiol. doi: 10.1016/j.ijmm.2016.03.006. [Epub ahead of print].
Smith, A. G., Croft, M. T., Moulin, M., and Webb, M. E.  Plants need their
vitamins too. Curr. Opin. Plant Biol. 10, 266–275. doi: 10.1016/j.pbi.2007.04.009
Smith, C. A., O’Maille, G., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R.,
et al.  METLIN: a metabolite mass spectral database. Ther. Drug Monit.
27,747–751. doi: 10.1097/01.ftd.0000179845.53213.39.

Smith, E. A., and Macfarlane, G. T.  Dissimilatory amino Acid metabolism
in human colonic bacteria. Anaerobe 3, 327–337. doi: 10.1006/anae.1997.0121
Smolinska, A., Blanchet, L., Buydens, L. M. C., and Wijmenga, S. S. 
NMR and pattern recognition methods in metabolomics: from data acquisition
to biomarker discovery: a review. Anal. Chim. Acta 750, 82–97. doi:
10.1016/j.aca.2012.05.049.

Srinivasan, S., Morgan, M. T., Fiedler, T. L., Djukovic, D., Hoﬀman, N. G.,
Raftery, D., et al.  Metabolic signatures of bacterial vaginosis. MBio 6,
e00204–e00215. doi: 10.1128/mBio.00204-15.

Stanton, C., Ross, R. P., Fitzgerald, G. F., and Van Sinderen, D.  Fermented
functional foods based on probiotics and their biogenic metabolites. Curr. Opin.
Biotechnol. 16, 198–203. doi: 10.1016/j.copbio.2005.02.008.

 Analysis
from Colombian Xylopia aromatica
of volatile secondary metabolites
(Lamarck) by diﬀerent
extraction and headspace methods and gas
chromatography. J. Chromatogr. A 1025, 105–113. doi: 10.1016/j.chroma.2003.
10.059.

Stephens, N. S., Siﬄedeen, J., Su, X., Murdoch, T. B., Fedorak, R. N., and
Slupsky, C. M.  Urinary NMR metabolomic proﬁles discriminate
inﬂammatory bowel disease from healthy. J. Crohns Colitis 7, e42–e48. doi:
10.1016/j.crohns.2012.04.019.

Sugawara, T., Sawada, D., Ishida, Y., Aihara, K., Aoki, Y., Takehara, I., et al.
 Regulatory eﬀect of paraprobiotic Lactobacillus gasseri CP2305 on gut
environment and function. Microb. Ecol. Health Dis. 27:30259. doi: 10.3402/
mehd.v27.30259.

Suttie, J. W.  The importance of menaquinones in human nutrition. Annu..

Tabanelli, G., Bargossi, E., Gardini, A., Lanciotti, R., Magnani, R., Gardini,
F., et al.  Physico-chemical and microbiological characterisation of
Italian fermented sausages in relation to their size: Italian fermented sausages
characterisation. J. Sci. Food Agric. 96, 2773–2781. doi: 10.1002/jsfa.7442.

Tabanelli, G., Vernocchi, P., Patrignani, F., Del Chierico, F., Putignani, L.,
Vinderola, G., et al.  Eﬀects of sub-lethal high-pressure homogenization
treatment on the outermost cellular structures and the volatile-molecule
proﬁles of two strains of probiotic lactobacilli. Front. Microbiol. 6:1006. doi:
10.3389/fmicb.2015.01006.

Taverniti, V., and Guglielmetti, S.  Health-promoting properties of
Lactobacillus helveticus. Front. Microbiol. 3:392. doi: 10.3389/fmicb.2012.00392
Vaidyanathan, S., Kell, D. B., and Goodacre, R.  Flow-injection electrospray
ionization mass spectrometry of crude cell extracts for high-throughput
bacterial
J. Am. Soc. Mass Spectrom. 13, 118–128. doi:
identiﬁcation.
10.1016/S1044-03050339-7.

Vannini, L., Patrignani, F., Iucci, L., Ndagijimana, M., Vallicelli, M., Lanciotti,
R., et al.  Eﬀect of a pre-treatment of milk with high pressure
homogenization on yield as well as on microbiological, lipolytic and proteolytic
patterns of “Pecorino” cheese. Int. J. Food Microbiol. 128, 329–335. doi:
10.1016/j.ijfoodmicro.2008.09.018.

van Zanten, G. C., Krych, L., Röytiö, H., Forssten, S., Lahtinen, S. J., Al-
Soud, W. A., et al.  Synbiotic Lactobacillus acidophilus NCFM and
cellobiose does not aﬀect human gut bacterial diversity but increases abundance
of lactobacilli, biﬁdobacteria and branched-chain fatty acids: a randomized,
double-blinded cross-over trial. FEMS Microbiol. Ecol. 90, 225–236. doi:
10.1111/1574-6941.12397.

Velázquez, O. C., Lederer, H. M., and Rombeau, J. L.  Butyrate and the
colonocyte. Production, absorption, metabolism, and therapeutic implications.
Adv. Exp. Med. Biol. 427, 123–134. doi: 10.1007/978-1-4615-5967-2_14.

Vernocchi, P., Ndagijimana, M., Serrazanetti, D. I., López, C. C., Fabiani, A.,
Gardini, F., et al.  Use of Saccharomyces cerevisiae strains endowed
with β-glucosidase activity for the production of Sangiovese wine. World J.
Microbiol. Biotechnol. 27, 1423–1433. doi: 10.1007/s11274-010-0594-1.

Vernocchi, P., Vannini, L., Gottardi, D., Del Chierico, F., Serrazanetti, D. I.,
Ndagijimana, M., et al.  Integration of datasets from diﬀerent analytical
techniques to assess the impact of nutrition on human metabolome. Front. Cell.
Infect. Microbiol. 2:156. doi: 10.3389/fcimb.2012.00156.

Veselkov, K. A., Lindon, J. C., Ebbels, T. M. D., Crockford, D., Volynkin, V. V.,
Holmes, E., et al.  Recursive segment-wise peak alignment of biological
 NMR spectra for improved metabolic biomarker recovery. Anal. Chem.
81, 56–66. doi: 10.1021/ac8011544.

Villas-Bôas, S. G., Mas, S., Akesson, M., Smedsgaard, J., and Nielsen, J.  Mass
spectrometry in metabolome analysis. Mass Spectrom. Rev. 24, 613–646. doi:
10.1002/mas.20032.

Villaseñor, A., Kinross, J. M., Li, J. V., Penney, N., Barton, R. H., Nicholson, J.
K., et al.  1H NMR global metabolic phenotyping of acute pancreatitis
in the emergency unit.
J. Proteome Res. 5, 362–375. doi: 10.1021/pr5
00161w.

Vitali, B., Ndagijimana, M., Cruciani, F., Carnevali, P., Candela, M., Guerzoni,
M. E., et al.  Impact of a synbiotic food on the gut microbial
ecology and metabolic proﬁles. BMC Microbiol. 10:4. doi: 10.1186/1471-
2180-10-4.

Vitali, B., Ndagijimana, M., Maccaferri, S., Biagi, E., Guerzoni, M. E., and Brigidi,
P.  An in vitro evaluation of the eﬀect of probiotics and prebiotics
on the metabolic proﬁle of human microbiota. Anaerobe 18, 386–391. doi:
10.1016/j.anaerobe.2012.04.014.

Walker, A., Lucio, M., Pﬁtzner, B., Scheerer, M. F., Neschen, S., de Angelis, M.
H., et al.  Importance of sulfur-containing metabolites in discriminating
fecal extracts between normal and type-2 diabetic mice. J. Proteome Res. 13,
4220–4231. doi: 10.1021/pr500046b.

Walton, C., Fowler, D. P., Turner, C., Jia, W., Whitehead, R. N., Griﬃths, L.,
et al.  Analysis of volatile organic compounds of bacterial origin in
chronic gastrointestinal diseases. Inﬂamm. Bowel Dis. 19, 2069–2078. doi:
10.1097/MIB.0b013e31829a91f6.

Wang, T., Carroll, W., Lenny, W., Boit, P., and Smith, D.  The analysis
of 1-propanol and 2-propanol in humid air samples using selected ion ﬂow
tube mass spectrometry. Rapid Commun. Mass Spectrom. 20, 125–130. doi:
10.1002/rcm.2285.

Weckwerth, W., and Morgenthal, K.  Metabolomics:.

Williams, H. R. T., Cox, I. J., Walker, D. G., Cobbold, J. F. L., Taylor-Robinson,
S. D., Marshall, S. E., et al.  Diﬀerences in gut microbial metabolism
are responsible for reduced hippurate synthesis in Crohn’s disease. BMC
Gastroenterol. 10:108. doi: 10.1186/1471-230X-10-108.

July 2016 | Volume 7 | Article 1144.

Wilson, M.  Microbial Inhabitants of Human. Cambridge; New York, NY:.

Wissenbach, D. K., Oliphant, K., Rolle-Kampczyk, U., Yen, S., Höke, H., Baumann,
S., et al.  Optimization of metabolomics of deﬁned in vitro gut microbial
ecosystems. Int. J. Med. Microbiol. doi: 10.1016/j.ijmm.2016.03.007. [Epub
ahead of print]..

Worley, B., and Powers, R.  Multivariate analysis in metabolomics. Curr..

 Deﬁning the
size, ﬂux, and regulation. Mol. Cell 58, 699–706. doi:.

Zhang, G., Bai, H., Zhang, H., Dean, C., Wu, Q., Li, J., et al.  Neuropeptide
exocytosis
involving synaptotagmin-4 and oxytocin in hypothalamic
programming of body weight and energy balance. Neuron 69, 523–535.
doi: 10.1016/j.neuron.2010.12.036.

Zhang, A., Sun, H., and Wang, X.  Saliva metabolomics opens door
to biomarker discovery, disease diagnosis, and treatment. Appl. Biochem.
Biotechnol. 168, 1718–1727. doi: 10.1007/s12010-012-9891-5.

Zhao, L., and Hartung, T.  Metabonomics and toxicology. Methods Mol..

Zhao, L., Liu, X., Xie, L., Gao, H., and Lin, D.  1H NMR-based metabonomic
analysis of metabolic changes in streptozotocin-induced diabetic rats. Anal. Sci.
Int. J. Jpn. Soc. Anal. Chem. 26, 1277–1282. doi: 10.2116/analsci.26.1277.

Zheng, X., Xie, G., Zhao, A., Zhao, L., Yao, C., Chiu, N. H. L., et al.  The
footprints of gut microbial-mammalian co-metabolism. J. Proteome Res. 10,
5512–5522. doi: 10.1021/pr2007945.

July 2016 | Volume 7 | Article 1144